Albert David Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Mar 2017

NOTES :
1. The above Financial Results and the Statement of Assets and Liabilities were reviewed by the Audit Committee and were thereafter approved by the Board of Directors of the Company at their meeting held on 30th May, 2017.

2. This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

3. The Board of Directors of the Company have recommended dividend of Rs. 5.50/- per equity share of Rs. 10/- each for the financial year ended 31st March, 2017, subject to approval of the Shareholders at the ensuing Annual General Meeting.

4. Based on the guiding principles given in Accounting Standard on Segment Reporting (AS - 17) specified in the Companies (Accounts) Rules, 2014, the Company's priomary business segment is Pharmaceutical. As the Company's business activity falls within a single primary business segment, the disclosure requirements of AS - 17 in this regard are not applicable.

5. Exceptional item represents consideration money received for sale of brand during the quarter and year ended 31st March, 2016 for Rs. 4080.75 lacs (net of related expenses and tax).

6. The figures for the last quarter are the balancing figures between the audited figures in respect of the full financial year and the published year-to-date figures upto the third quarter of the financial year.

7. Figures for the previous period are re-classified/ re-arranged/ re-grouped, wherever neccessary, to correspond with the current period's classification/ disclosure.



For Albert David Ltd.
Sd/-
H. P. Kabra
Executive Director
DIN: 00385240
Place: Kolkata
Date: 30th May, 2017